UPC CoA 36/2026
25. Feb. 2026·EP4346690: AUTOMATED MANAGEMENT OF CLINICAL MODIFICATIONS TO TREATMENT PLANS USING THREE-DIMENSIONAL CONTROLS
- Verfahrensdetails
- StatusCase ClosedVerfahrensartBerufungKategorieHauptberufung
- Parteien
- Kläger
- Angelalign Technology Inc.
- Angelalign France Technology SASU
- Europe Angelalign Technology B.V.
- Angelalign Technology (Germany) GmbH
- Italy Angelalign Technology S.R.L.
- Shanghai EA Medical Instruments Co., Ltd.
Vertreter: Agathe Michel-De Cazotte (Carpmaels & Ransford) - Division
- Court of Appeal
- Technology
- Healthcare Informatics
- Sprache
- English
- Erste Entscheidung
- 8. Juli 2026
- 2026-07-08PI erteiltBerufungsentscheidungAppeal RoP220.1
The Court of Appeal rejected the Appellants' appeal against the Local Division Düsseldorf's order of 12 February 2026 granting a preliminary injunction. The CoA found it more likely than not that EP 4 346 690 is valid and that Appellants directly infringe claims 1 and 13 and indirectly infringe claim 15 via the iOrtho software 'Live Now' feature; the provisional measures ordered by the LD are maintained. Appellants were ordered to bear the costs of the appeal proceedings.
Rechtsfragen:Admissibility of late-filed non-infringement arguments under R. 222.2 RoPAdmissibility of new prior art exhibits (AR09, AR10) filed for the first time on appealClaim construction of features 1.5, 1.6 and 1.7 of claim 1 (real-time modification, predetermined threshold determination, conditional generation of revised treatment plan)Novelty of claims 1, 13 and 15 over D2 (US 2019/0175303 A1) and D6 (3Shape Clear Aligner Studio YouTube video)Inventive step over D1, D2, D6, D7 and D8 individually and in combinationInfringement of claims 1 and 13 (direct) and claim 15 (indirect) by iOrtho software 'Live Now' feature (scenario 1) and other scenariosBalance of interests and necessity of provisional measures under Art. 62 UPCA and R. 211.3 RoPCosts allocation under Art. 69(1) UPCA
| Dokumenttitel | Datum | Öffentlich |
|---|---|---|
| action.phaseChange.caseClose | 2026-07-08 | Nicht öffentlich |
| Final Order | 2026-07-08 | Öffentlich |
| action.issueDecision.decision | 2026-07-08 | Nicht öffentlich |
| Final Order | 2026-07-08 | Nicht öffentlich |
| action.phaseChange.deliberationPhaseOpen | 2026-06-18 | Nicht öffentlich |
| action.phaseChange.oralPhaseClose | 2026-06-18 | Nicht öffentlich |
| Hearing recording reference document | 2026-06-18 | Nicht öffentlich |
| action.phaseChange.oralPhaseOpen | 2026-03-27 | Nicht öffentlich |
| action.phaseChange.writtenPhaseClose | 2026-03-27 | Nicht öffentlich |
| action.summons.oralHearing | 2026-03-27 | Nicht öffentlich |
| Summons | 2026-03-27 | Öffentlich |
| Receipt | 2026-03-27 | Nicht öffentlich |
| Cover sheet | 2026-03-27 | Nicht öffentlich |
| Document Respondent | 2026-03-27 | Nicht öffentlich |
| Formal Deficiency found | 2026-03-27 | Nicht öffentlich |
| Receipt | 2026-03-25 | Nicht öffentlich |
| Cover sheet | 2026-03-25 | Nicht öffentlich |
| Statement of Response | 2026-03-25 | Nicht öffentlich |
| action.issueOrder.order | 2026-03-24 | Nicht öffentlich |
| Order | 2026-03-24 | Öffentlich |
| Order | 2026-03-24 | Öffentlich |
| Receipt | 2026-03-19 | Nicht öffentlich |
| Cover sheet | 2026-03-19 | Nicht öffentlich |
| Document | 2026-03-19 | Nicht öffentlich |
| Note | 2026-03-19 | Nicht öffentlich |
| Document | 2026-03-19 | Nicht öffentlich |
| Document | 2026-03-19 | Nicht öffentlich |
| Document | 2026-03-19 | Nicht öffentlich |
| action.communication.general | 2026-03-19 | Nicht öffentlich |
| action.communication.general | 2026-03-19 | Nicht öffentlich |
| Receipt | 2026-03-18 | Nicht öffentlich |
| Cover sheet | 2026-03-18 | Nicht öffentlich |
| Other document Appellant | 2026-03-18 | Nicht öffentlich |
| Other document Appellant | 2026-03-18 | Nicht öffentlich |
| action.publishOrderDecision.case | 2026-03-10 | Nicht öffentlich |
| Receipt | 2026-03-09 | Nicht öffentlich |
| Cover sheet | 2026-03-09 | Nicht öffentlich |
| Other document Appellant | 2026-03-09 | Nicht öffentlich |
| Other document Appellant | 2026-03-09 | Nicht öffentlich |
| Exhibit Appellant | 2026-03-09 | Nicht öffentlich |
| Exhibit Appellant | 2026-03-09 | Nicht öffentlich |
| Formal Deficiency found | 2026-03-03 | Nicht öffentlich |
| Receipt | 2026-02-27 | Nicht öffentlich |
| Cover sheet | 2026-02-27 | Nicht öffentlich |
| Statement of the Grounds of Appeal | 2026-02-27 | Nicht öffentlich |
| Other document Appellant | 2026-02-27 | Nicht öffentlich |
| Other document Appellant | 2026-02-27 | Nicht öffentlich |
| Other document Appellant | 2026-02-27 | Nicht öffentlich |
| Receipt | 2026-02-25 | Nicht öffentlich |
| Cover sheet | 2026-02-25 | Nicht öffentlich |
| Fee | 2026-02-25 | Nicht öffentlich |
| Statement of Appeal | 2026-02-25 | Nicht öffentlich |
The non-infringement arguments regarding scenario 1 (paragraphs 13-17 of the Rejoinder) should be admitted on appeal as they were uncontested and Respondent had ample opportunity to respond
BeklagterRechtsgrundlage: R. 222.2 RoP; UPC_CoA_534/2024; UPC_CoA_622/2025; UPC_CoA_623/2025New exhibits AR09 and AR10 should be disregarded as they constitute a new invalidity attack that could and should have been filed at first instance, and allowing them would deprive Respondent of one instance to defend
KlägerRechtsgrundlage: R. 222.2 RoPClaims 1, 13 and 15 are novel over D2 because D2 does not disclose the two-step mechanism of features 1.6 and 1.7 (threshold determination preceding and governing treatment plan generation)
KlägerRechtsgrundlage: Art. 54(1) EPC; claim construction of features 1.6 and 1.7Claims 1, 13 and 15 are novel over D6 because D6 does not disclose feature 1.7 (generation of revised treatment plan only when user modification is within a predetermined threshold)
KlägerRechtsgrundlage: Art. 54(1) EPCClaims 1, 13 and 15 have inventive step over all prior art combinations relied upon by Appellants (D1, D2, D6, D7, D8)
KlägerRechtsgrundlage: Art. 56 EPC; problem-solution approach as per UPC_CoA_528/2024 and UPC_CoA_529/2024In scenario 1, the iOrtho software infringes claims 1 and 13 directly and claim 15 indirectly because the gingival line functions as a predetermined threshold (feature 1.6) and a revised treatment plan is generated only when the attachment is within that threshold (feature 1.7)
KlägerRechtsgrundlage: Claims 1, 13 and 15 of EP 4 346 690Respondent's interests in an injunction outweigh Appellants' interests in continuing to offer the infringing 'Live Now' feature, given direct competition and risk of lasting market share loss
KlägerRechtsgrundlage: Art. 62(2) UPCA; R. 211.3 RoP
Non-infringement arguments regarding scenarios 2 and 3 should be admitted on appeal
BeklagterRechtsgrundlage: R. 222.2 RoPThe iOrtho software does not infringe claim 1 in scenario 1 because only compliant modification requests are allowed by the software and thus no determination within feature 1.6 is made
BeklagterRechtsgrundlage: Claims 1, 13 and 15 of EP 4 346 690D2 anticipates claims 1, 13 and 15 because its constraints constitute predetermined thresholds within the meaning of features 1.6 and 1.7
BeklagterRechtsgrundlage: Art. 54(1) EPCD6 anticipates claims 1, 13 and 15
BeklagterRechtsgrundlage: Art. 54(1) EPCThe patented invention is obvious over D1 in combination with common general knowledge
BeklagterRechtsgrundlage: Art. 56 EPCThe patented invention is obvious over D2 in combination with common general knowledge or D6
BeklagterRechtsgrundlage: Art. 56 EPCThe patented invention is obvious over D6 in combination with common general knowledge or D2
BeklagterRechtsgrundlage: Art. 56 EPCThe patented invention is obvious over D7 in combination with common general knowledge or D8
BeklagterRechtsgrundlage: Art. 56 EPCThe balance of interests does not justify the provisional measures because Appellants' market position and damages are difficult to quantify and other competitors exist
BeklagterRechtsgrundlage: Art. 62(2) UPCA; R. 211.3 RoP